Results 51 to 60 of about 823 (162)
Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature
Objectives: To review the clinical and laboratory features of twelve cases of nephrogenic fibrosing dermopathy (NFD) studied at our institution and of 70 previously described cases in the literature. Methods: Clinical evaluation and laboratory studies
Latinis, Kevin +5 more
core
Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations
BACKGROUND: The condition that came to be known as nephrogenic systemic fibrosis (NSF) was first reported in 2000 and, in 2001, was termed "nephrogenic fibrosing dermopathy." Since then, NSF has been the subject of a wide-ranging multidisciplinary ...
Elston, Dirk M. +5 more
core +1 more source
Nephrogenic systemic fibrosis (NSF), previously known as nephrogenic fibrosing dermopathy, is a debilitating skin condition that causes fibrotic changes in the setting of renal failure.
Safai, Bijan +3 more
core +1 more source
Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases
The aim of this article is to review the published cases of nephrogenic systemic fibrosis (NSF) in Japan. The Japanese medical literature database and MedLine were searched using the keywords NSF and nephrogenic fibrosing dermopathy (January 2000 to ...
Thomsen, H S +5 more
core +1 more source
SummaryNine unusual bleeding and clotting disorders (or mimickers of such) are described in the format of case presentations, with focus on clinical history, images and diagnostic tests, followed by a discussion of the disease itself and a summarizing ...
S. Moll
core +1 more source
Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin
ope
정기양
core +1 more source
Multiple well-demarcated skin-colored papules and nodules. [PDF]
Santa Lucia G +4 more
europepmc +1 more source
The Quest to Reduce the Use of Gadolinium-based Contrast Agents: AI May Provide a Solution. [PDF]
Bahl M.
europepmc +1 more source
Cutaneous manifestations in patients with end-stage renal disease on hemodialysis. [PDF]
Shirzadian Kebria A +3 more
europepmc +1 more source

